{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T16:29:05Z","timestamp":1747153745207,"version":"3.40.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s10096-024-04939-z","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T12:02:19Z","timestamp":1726142539000},"page":"2171-2176","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The long-term impact of an antimicrobial stewardship program in febrile neutropenia: an 8 years follow up"],"prefix":"10.1007","volume":"43","author":[{"given":"Bahar","family":"Madran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u015eiran","family":"Keske","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burhan","family":"Ferhano\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nil M.","family":"Mandel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1935-9235","authenticated-orcid":false,"given":"\u00d6nder","family":"Erg\u00f6n\u00fcl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,12]]},"reference":[{"issue":"3","key":"4939_CR1","doi-asserted-by":"publisher","first-page":"e234881","DOI":"10.1001\/jamanetworkopen.2023.4881","volume":"6","author":"CJ Baus","year":"2023","unstructured":"Baus CJ et al (2023) Neutropenic Fever-Associated admissions among patients with solid tumors receiving Chemotherapy during the COVID-19 pandemic. JAMA Netw Open 6(3):e234881","journal-title":"JAMA Netw Open"},{"issue":"4","key":"4939_CR2","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1093\/cid\/cir073","volume":"52","author":"AG Freifeld","year":"2011","unstructured":"Freifeld AG et al (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America. Clin Infect Dis 52(4):e56\u201393","journal-title":"Clin Infect Dis"},{"issue":"3","key":"4939_CR3","first-page":"273","volume":"5","author":"AA Rasmy","year":"2016","unstructured":"Rasmy AA, Fotih A, Selwi S (2016) Febrile neutropenia in cancer patient: epidemiology, microbiology, pathophysiology and management. J Cancer Prev Curr Res 5(3):273\u2013278","journal-title":"J Cancer Prev Curr Res"},{"issue":"16","key":"4939_CR4","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1200\/JCO.2000.18.16.3038","volume":"18","author":"J Klastersky","year":"2000","unstructured":"Klastersky J et al (2000) The Multinational Association for Supportive Care in Cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 18(16):3038\u20133051","journal-title":"J Clin Oncol"},{"issue":"6","key":"4939_CR5","doi-asserted-by":"publisher","first-page":"e552","DOI":"10.1200\/JOP.2016.019588","volume":"13","author":"E Tai","year":"2017","unstructured":"Tai E et al (2017) Cost of Cancer-related Neutropenia or Fever hospitalizations, United States, 2012. J Oncol Pract 13(6):e552\u2013e561","journal-title":"J Oncol Pract"},{"doi-asserted-by":"crossref","unstructured":"Hosiriluck N et al (2015) Prognostic factors for mortality with febrile neutropenia in hospitalized patients. Southwest Respiratory Clin Care Chronicles, 3(9)","key":"4939_CR6","DOI":"10.12746\/swrccc2015.0309.112"},{"issue":"8","key":"4939_CR7","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/oncolo\/oyac074","volume":"27","author":"R Boccia","year":"2022","unstructured":"Boccia R et al (2022) Chemotherapy-Induced Neutropenia and Febrile Neutropenia in the US: a Beast of Burden that needs to be tamed? Oncologist 27(8):625\u2013636","journal-title":"Oncologist"},{"doi-asserted-by":"crossref","unstructured":"Ishikawa K et al (2023) Systematic review of the short-term versus long-term duration of Antibiotic Management for Neutropenic Fever in patients with Cancer. Cancers (Basel), 15(5)","key":"4939_CR8","DOI":"10.3390\/cancers15051611"},{"key":"4939_CR9","first-page":"204993612211383","volume":"9","author":"JM Keck","year":"2022","unstructured":"Keck JM et al (2022) Approach to fever in patients with neutropenia: a review of diagnosis and management. Ther Adv Infect Dis 9:20499361221138346","journal-title":"Ther Adv Infect Dis"},{"issue":"12","key":"4939_CR10","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.3324\/haematol.2013.091025","volume":"98","author":"D Averbuch","year":"2013","unstructured":"Averbuch D et al (2013) European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European conference on infections in Leukemia. Haematologica 98(12):1826\u20131835","journal-title":"Haematologica"},{"issue":"1","key":"4939_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s15010-013-0525-9","volume":"42","author":"L Nesher","year":"2014","unstructured":"Nesher L, Rolston KV (2014) The current spectrum of infection in cancer patients with chemotherapy related neutropenia. Infection 42(1):5\u201313","journal-title":"Infection"},{"issue":"6","key":"4939_CR12","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.cmi.2019.02.024","volume":"25","author":"B Isler","year":"2019","unstructured":"Isler B et al (2019) Antibiotic overconsumption and resistance in Turkey. Clin Microbiol Infect 25(6):651\u2013653","journal-title":"Clin Microbiol Infect"},{"unstructured":"P\u0131narl\u0131k F, G\u00fccer LS, Boral J, Ekinci G, Cooper FK, Ata\u00e7 N (2023) Klebsiella pneumoniae: surveillance of antimicrobial resistance, clinical and molecular characteristics. ; https:\/\/elibrary.escmid.org\/?search%5Bfrom%5D=0&search%5Bquery%5D=P\u0130NARLIK&search%5Bdate%5D=#results","key":"4939_CR13"},{"issue":"14","key":"4939_CR14","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1200\/JCO.2017.77.6211","volume":"36","author":"RA Taplitz","year":"2018","unstructured":"Taplitz RA et al (2018) Outpatient Management of Fever and Neutropenia in adults treated for malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update. J Clin Oncol 36(14):1443\u20131453","journal-title":"J Clin Oncol"},{"issue":"12","key":"4939_CR15","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.6004\/jnccn.2017.0175","volume":"15","author":"J Crawford","year":"2017","unstructured":"Crawford J et al (2017) NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 15(12):1520\u20131541","journal-title":"J Natl Compr Canc Netw"},{"issue":"11","key":"4939_CR16","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.6004\/jnccn.2012.0146","volume":"10","author":"LR Baden","year":"2012","unstructured":"Baden LR et al (2012) Prevention and treatment of cancer-related infections. J Natl Compr Canc Netw 10(11):1412\u20131445","journal-title":"J Natl Compr Canc Netw"},{"issue":"6","key":"4939_CR17","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1200\/JCO.2012.45.8661","volume":"31","author":"CR Flowers","year":"2013","unstructured":"Flowers CR et al (2013) Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 31(6):794\u2013810","journal-title":"J Clin Oncol"},{"issue":"4","key":"4939_CR18","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.ajic.2017.09.030","volume":"46","author":"B Madran","year":"2018","unstructured":"Madran B et al (2018) Implementation of an antimicrobial stewardship program for patients with febrile neutropenia. Am J Infect Control 46(4):420\u2013424","journal-title":"Am J Infect Control"},{"issue":"1","key":"4939_CR19","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13756-022-01084-0","volume":"11","author":"A Contejean","year":"2022","unstructured":"Contejean A et al (2022) Antimicrobial stewardship in high-risk febrile neutropenia patients. Antimicrob Resist Infect Control 11(1):52","journal-title":"Antimicrob Resist Infect Control"},{"doi-asserted-by":"crossref","unstructured":"Hosiriluck N, Saranapoom K, Rassameehiran S, Sutamtewagul G, Tijani L, Radhi S (2015) Prognostic factors for mortality with febrile neutropenia in hospitalized patients, vol 3. The Southwest Respiratory and Critical Care Chronicles, 9","key":"4939_CR20","DOI":"10.12746\/swrccc2015.0309.112"},{"issue":"2","key":"4939_CR21","doi-asserted-by":"publisher","first-page":"87","DOI":"10.36519\/idcm.2022.141","volume":"4","author":"CM Ayaz","year":"2022","unstructured":"Ayaz CM, Haz\u0131rolan G, Sancak B, Has\u00e7elik G, Akova M (2022) Factors associated with gram-negative bacteremia and mortality in neutropenic patients with haematologic malignancies in a high-resistance setting. Infect Disease Clin Microbiol 4(2):87\u201398","journal-title":"Infect Disease Clin Microbiol"},{"key":"4939_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ijid.2021.10.011","volume":"114","author":"O Ergonul","year":"2022","unstructured":"Ergonul O et al (2022) Elimination of healthcare-associated Acinetobacter baumannii infection in a highly endemic region. Int J Infect Dis 114:11\u201314","journal-title":"Int J Infect Dis"},{"issue":"2","key":"4939_CR23","doi-asserted-by":"publisher","first-page":"190","DOI":"10.5152\/kd.2019.41","volume":"32","author":"\u015e Keske","year":"2019","unstructured":"Keske \u015e (2019) The significance of Multidirectional Studies in Control of Health Care-Associated Infections. KLIMIK J 32(2):190\u2013194","journal-title":"KLIMIK J"},{"issue":"10","key":"4939_CR24","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1007\/s10096-018-3328-1","volume":"37","author":"G la Martire","year":"2018","unstructured":"la Martire G et al (2018) De-escalation and discontinuation strategies in high-risk neutropenic patients: an interrupted time series analyses of antimicrobial consumption and impact on outcome. Eur J Clin Microbiol Infect Dis 37(10):1931\u20131940","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"4939_CR25","doi-asserted-by":"publisher","first-page":"ofab624","DOI":"10.1093\/ofid\/ofab624","volume":"9","author":"A Verlinden","year":"2022","unstructured":"Verlinden A et al (2022) Safety and efficacy of antibiotic de-escalation and discontinuation in high-risk hematological patients with febrile Neutropenia: a single-center experience. Open Forum Infect Dis 9(3):ofab624","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"4939_CR26","doi-asserted-by":"publisher","first-page":"e0263095","DOI":"10.1371\/journal.pone.0263095","volume":"17","author":"N Itoh","year":"2022","unstructured":"Itoh N et al (2022) Effects of infectious disease consultation and antimicrobial stewardship program at a Japanese cancer center: an interrupted time-series analysis. PLoS ONE 17(1):e0263095","journal-title":"PLoS ONE"},{"unstructured":"P\u0131narl\u0131k F, G\u00fccer LS, Boral J, Ekinci G, Cooper FK, Ata\u00e7 N (2023) The molecular characteristics of carbapenem resistant pseudomonas aeruginosa. [cited 2024; https:\/\/elibrary.escmid.org\/?search%5Bfrom%5D=0&search%5Bquery%5D=P\u0130NARLIK&search%5Bdate%5D=#results","key":"4939_CR27"},{"issue":"11","key":"4939_CR28","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1200\/OP.21.00148","volume":"17","author":"DT Wijeratne","year":"2021","unstructured":"Wijeratne DT, Wright K, Gyawali B (2021) Risk-stratifying treatment strategies for Febrile Neutropenia-Tools, Tools everywhere, and not a single one that works? JCO Oncol Pract 17(11):651\u2013654","journal-title":"JCO Oncol Pract"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-024-04939-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-024-04939-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-024-04939-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T14:04:29Z","timestamp":1730729069000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-024-04939-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,12]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["4939"],"URL":"https:\/\/doi.org\/10.1007\/s10096-024-04939-z","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"type":"print","value":"0934-9723"},{"type":"electronic","value":"1435-4373"}],"subject":[],"published":{"date-parts":[[2024,9,12]]},"assertion":[{"value":"4 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}